Clinical application of human umbilical cord-derived mesenchymal stem cells for small articular cartilage defects of the knee in military training-related injuries
Zhao G., Xue C., Li B., Jin W., Liu X.
Retrospective Study with a reported sample of 11 on Cartilage Damage, published in Pak J Med Sci (2025) — summary generated from the PubMed abstract.
Early human evidence such as case series or small samples is exploring possible benefits.
- Level A · Stronger Clinical Evidence
- Level B · Emerging clinical evidence with positive signals
- Level C · Early human research exploring benefits
- Level D · Scientific groundwork from lab and animal studies
- Emerging · Emerging topic under active research
This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.
- Study type
- Retrospective Study
- Journal
- Pak J Med Sci (2025)
- Reported sample size
- 11
- Source database
- Europe PMC
- PMID
- 40980389
- PMCID
- PMC12444110
- DOI
- 10.12669/pjms.41.8.10803
Abstract (original English)
Objective To explore the short-term efficacy and safety of umbilical cord-derived mesenchymal stem cells(UC-MSCs) in patients with small articular cartilage defects of the knee. Methods This was a retrospective study from August 2020 to December 2020, thirty two patients with knee cartilage injuries caused by military training were admitted to the Department of Orthopedics in The General Hospital of North Theater Command Training Base included in the study. Group-A (n=11) underwent microfracture surgery, Group-B(n=10) underwent arthroscopic exploration and injected umbilical cord mesenchymal stem cells (UC MSCs) into the knee joint cavity, and Group-C (n=11) underwent microfracture surgery and injected UC MSCs into the knee joint cavity. Clinical data were collected from three groups of patients. Results The Lysholm scores of the three groups gradually increased, from 51.00 ± 1.6, 51.50 ± 2.2, and 50.91 ± 2.4 points before treatment to 74.64 ± 2.4, 79.40 ± 4.3, and 78.73 ± 4.2 points at the last follow-up (P 0.05). Conclusion The application of microfracture combined with UC MSCs injection or UC MSCs injection alone for small cartilage defects in the knee joint can achieve certain therapeutic effects in the short term, but as a new technology, stem cells need further observation for long-term efficacy.
What this study does not prove
- • This study does not prove SVF is an approved treatment or a replacement for standard care.
- • Without an adequate control group, treatment effects cannot be separated from other factors.
Evidence level
Early human evidence such as case series or small samples is exploring possible benefits.
How we grade evidenceBrowse all related research
Filter the research library by this study's title keywords, author, or publication year.
Related research
- Level ASystematic ReviewPubMed
A Systematic Review on Amnion as a Cell Delivery Scaffolding Material for Cartilage Regeneration in Pre-Clinical and Clinical Studies.
Systematic Review on Osteoarthritis, Cartilage Damage, published in Bioengineering (Basel) (2026) — summary generated from the PubMed abstract.
- 2026
Bioengineering (Basel)1 citations - Level ASystematic ReviewPubMed
Intra-articular adipose-derived cell therapies for knee osteoarthritis: a systematic review of randomized controlled trials.
Systematic Review on Knee Osteoarthritis, Osteoarthritis, Cartilage Damage, published in Front Med (Lausanne) (2026) — summary generated from the PubMed abstract.
- 2026
Front Med (Lausanne) - Level ASystematic ReviewEurope PMC
Subchondral Knee Injections: A Comprehensive Systematic Review of Current Clinical Outcomes, Safety, and Arthroplasty Delay
Systematic Review with a reported sample of 5 on Knee Osteoarthritis, Osteoarthritis, Cartilage Damage, published in Cartilage (2026) — summary generated from the PubMed abstract.
- 2026
- n = 5
Cartilage - Level AMeta-analysisEurope PMC
Mesenchymal stem cell-derived extracellular vesicles for osteochondral defect regeneration: a systematic review and meta-analysis of preclinical studies
Meta-analysis on Cartilage Damage, published in J Transl Med (2026) — summary generated from the PubMed abstract.
- 2026
J Transl Med - Level ASystematic ReviewEurope PMC
The role of costal cartilage in musculoskeletal regeneration: A systematic review
Systematic Review on Cartilage Damage, published in J Exp Orthop (2026) — summary generated from the PubMed abstract.
- 2026
J Exp Orthop - Level ASystematic ReviewPubMed
A Comparison of the Properties of Mesenchymal Stem Cells Derived from Different Synovial Sources: A Systematic Review.
Systematic Review on Osteoarthritis, Cartilage Damage, published in Int J Mol Sci (2026) — summary generated from the PubMed abstract.
- 2026
Int J Mol Sci